{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:10Z","timestamp":1753890910825,"version":"3.41.2"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory bowel disease (IBD) has been reported to be associated with risk of uterine cervical neoplasm. We aimed to evaluate the causal relationship between IBD and uterine cervical neoplasm using a bidirectional Mendelian randomization analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We derived instrumental variables for IBD, including Crohn\u2019s disease and ulcerative colitis, from the IEU Open genome-wide association study (GWAS) database, and for the histological subtypes of uterine cervical neoplasm from the FinnGen repository\u2019s GWAS data. The collected GWAS data predominantly represent individuals of European ancestry. The inverse-variance weighted (IVW) method was employed as primary analysis approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IBD (IVW odds ratio = 1.127, 95% confidence interval = 1.016\u20131.251; <jats:italic>p<\/jats:italic> = 0.024) and CD (IVW odds ratio = 1.119, 95% confidence interval = 1.023\u20131.224; <jats:italic>p<\/jats:italic> = 0.014) exhibited a significant causal effect on malignant cervical carcinoma. Sensitivity analyses confirmed these findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Genetically predicted IBD and CD are risk factors for the development of malignant cervical carcinoma. Patients with IBD and CD require specific attention to prevent cervical squamous cell carcinoma. Further studies to elucidate the underlying mechanisms may reveal new therapeutic targets.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2024.1436512","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:41Z","timestamp":1738046621000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization analysis reveals genetic evidence for a causal link between inflammatory bowel disease and uterine cervical neoplasms"],"prefix":"10.3389","volume":"15","author":[{"given":"Chunge","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.3390\/cancers15194878","article-title":"The relationship between furin and chronic inflammation in the progression of cervical intraepithelial neoplasia to cancer: a cross-sectional study","volume":"15","author":"Afsar","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Physiol. Behav."},{"key":"B3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cgh.2018.07.013","article-title":"Balancing benefit vs risk of immunosuppressive therapy for individual patients with inflammatory bowel diseases","volume":"17","author":"Beaugerie","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/sj.bjc.6601764","article-title":"Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis","volume":"90","author":"Berrington De Gonz\u00e1lez","year":"2004","journal-title":"Br. J. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1145950","DOI":"10.3389\/fcimb.2023.1145950","article-title":"Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis","volume":"13","author":"Chang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1111\/jog.14992","article-title":"Association between inflammatory bowel disease and risk of abnormalities of uterine cervix","volume":"47","author":"Cui","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12916-023-03096-y","article-title":"Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study","volume":"21","author":"Gao","year":"2023","journal-title":"BMC Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/ecco-jcc\/jjab036","article-title":"Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study","volume":"15","author":"Goetgebuer","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MEG.0b013e3282f2a5e2","article-title":"Cancer in patients with ulcerative colitis, Crohn\u2019s disease and coeliac disease: record linkage study","volume":"20","author":"Goldacre","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/HJH.0000000000003442","article-title":"Childhood obesity and hypertension in pregnancy: a two-sample Mendelian randomization analysis","volume":"41","author":"Hu","year":"2023","journal-title":"J. Hypertens."},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/cbt.11.3.14686","article-title":"Molecular pathogenesis of cervical cancer","volume":"11","author":"Ibeanu","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.crohns.2014.02.015","article-title":"Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland","volume":"8","author":"Jussila","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1093\/jcag\/gwad019","article-title":"The 2023 impact of inflammatory bowel disease in Canada: COVID-19 and IBD","volume":"6","author":"Kaplan","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.1038\/s41598-023-33476-6","article-title":"Elevated risk of cervical cancer in elderly women with incident ulcerative colitis in South Korea","volume":"13","author":"Kim","year":"","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1080\/00365521.2023.2238101","article-title":"Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis","volume":"58","author":"Kim","year":"","journal-title":"Scand. J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e00513","DOI":"10.14309\/ctg.0000000000000513","article-title":"Risk of cervical cancer in inflammatory bowel disease: a meta-analysis of population-based studies","volume":"13","author":"Mann","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/nejmoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.05.001","article-title":"Risk of colorectal cancer in inflammatory bowel diseases","volume":"64","author":"Nadeem","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn\u2019s disease inflammation and recurrence","volume":"15","author":"Petagna","year":"2020","journal-title":"Biol. Direct"},{"key":"B28","doi-asserted-by":"publisher","first-page":"733992","DOI":"10.3389\/fcimb.2022.733992","article-title":"The gut microbiota in inflammatory bowel disease","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines11010099","article-title":"Association between immunosuppressive therapy utilized in the treatment of autoimmune disease or transplant and cancer progression","volume":"11","author":"Reyes","year":"2023","journal-title":"Biomedicines"},{"key":"B30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1217165","DOI":"10.3389\/fendo.2023.1217165","article-title":"Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease","volume":"14","author":"Sahoo","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B35","article-title":"How long does cervical cancer take to develop?","author":"Thomas","year":"2023","journal-title":"Med. News Today"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1436512\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:43Z","timestamp":1738046623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1436512\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":35,"alternative-id":["10.3389\/fgene.2024.1436512"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1436512","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"article-number":"1436512"}}